{"id":"W2769831433","doi":"10.2147/ndt.s150589","title":"The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone","year":2017,"lang":"en","type":"review","venue":"Neuropsychiatric Disease and Treatment","topic":"Treatment of Major Depression","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Allergan","keywords":"Vortioxetine; Medicine; Discontinuation; Major depressive disorder; Antidepressant; Serotonin reuptake inhibitor; Tolerability; Nausea; Partial agonist; Placebo; Serotonergic; Adverse effect; Psychiatry; Internal medicine; Mood; Anxiety; Serotonin; Agonist; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003258994,0.0004464009,0.002254492,0.0001412587,0.00006259452,0.00001495425,0.0001648807,0.00009173115,0.000006950239],"category_scores_gemma":[0.001027483,0.0002615627,0.0003154602,0.000222117,0.00009310184,0.00007862697,0.0001016414,0.0002535024,0.000001159824],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001332372,"about_ca_system_score_gemma":0.004188853,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1695973,"about_ca_topic_score_gemma":0.06205284,"domain_scores_codex":[0.9966342,0.0004708604,0.001574484,0.0006292718,0.0004237512,0.0002674358],"domain_scores_gemma":[0.9962972,0.0008743359,0.001328255,0.001007331,0.00005735996,0.0004355024],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000407523,0.0009587807,0.0507011,0.01204451,0.000280239,0.0004950158,0.000007121278,4.841618e-8,3.297704e-8,0.00001502651,0.0003916885,0.9346989],"study_design_scores_gemma":[0.003458179,0.0004241754,0.1783759,0.04150444,0.00654577,0.00007442599,0.00000946245,0.000002341678,1.747005e-7,0.00001472793,0.7694298,0.0001605809],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002861214,0.9933606,6.873216e-8,0.0005682461,0.0001738776,0.002223298,0.00009963525,0.000006440451,0.0007066425],"genre_scores_gemma":[0.001807253,0.9976027,0.00007631534,0.00009653281,0.00009534533,0.00007851398,0.00004428248,0.00004107602,0.0001580013],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9345384,"threshold_uncertainty_score":0.9999837,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05069139812595359,"score_gpt":0.3892445612285179,"score_spread":0.3385531631025643,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}